undefined

Potent Inhibitor of Human Trypsins from the Aeruginosin Family of Natural Products

Publiceringsår

2021

Upphovspersoner

Ahmed, Muhammad N.; Wahlsten, Matti; Jokela, Jouni; Nees, Matthias; Stenman, Ulf-Håkan; Alvarenga, Danillo O.; Strandin, Tomas; Sivonen, Kaarina; Poso, Antti; Permi, Perttu; Metsä-Ketelä, Mikko; Koistinen, Hannu; Fewer, David P.

Abstrakt

Serine proteases regulate many physiological processes and play a key role in a variety of cancers. Aeruginosins are a family of natural products produced by cyanobacteria that exhibit pronounced structural diversity and potent serine protease inhibition. Here, we sequenced the complete genome of Nodularia sphaerocarpa UHCC 0038 and identified the 43.7 kb suomilide biosynthetic gene cluster. Bioinformatic analysis demonstrated that suomilide belongs to the aeruginosin family of natural products. We identified 103 complete aeruginosin biosynthetic gene clusters from 12 cyanobacterial genera and showed that they encode an unexpected chemical diversity. Surprisingly, purified suomilide inhibited human trypsin-2 and -3, with IC50 values of 4.7 and 11.5 nM, respectively, while trypsin-1 was inhibited with an IC50 of 104 nM. Molecular dynamics simulations suggested that suomilide has a long residence time when bound to trypsins. This was confirmed experimentally for trypsin-1 and -3 (residence times of 1.5 and 57 min, respectively). Suomilide also inhibited the invasion of aggressive and metastatic PC-3M prostate cancer cells without affecting cell proliferation. The potent inhibition of trypsin-3, together with a long residence time and the ability to inhibit prostate cancer cell invasion, makes suomilide an attractive drug lead for targeting cancers that overexpress trypsin-3. These results substantially broaden the genetic and chemical diversity of the aeruginosin family and suggest that aeruginosins may be a source of selective inhibitors of human serine proteases.
Visa mer

Organisationer och upphovspersoner

Åbo universitet

Nees Matthias

Metsä-Ketelä Mikko

Helsingfors universitet

Poso Antti

Alvarenga Danillo O.

Fewer David P.

Koistinen Hannu

Jokela Jouni

Sivonen Kaarina

Wahlsten Matti

Ahmed Muhammad N.

Permi Perttu

Strandin Tomas

Stenman Ulf Håkan

Helsingfors universitetssjukhus

Poso Antti

Alvarenga Danillo O.

Fewer David P.

Koistinen Hannu

Jokela Jouni

Sivonen Kaarina

Wahlsten Matti

Ahmed Muhammad N.

Permi Perttu

Strandin Tomas

Stenman Ulf Håkan

Publikationstyp

Publikationsform

Artikel

Rapport

Nej

Moderpublikationens typ

Tidning

Artikelstyp

En originalartikel

Målgrupp

Vetenskaplig

Kollegialt utvärderad

Kollegialt utvärderad

UKM:s publikationstyp

A1 Originalartikel i en vetenskaplig tidskrift

Publikationskanalens uppgifter

Moderpublikationens namn

ACS Chemical Biology

Volym

16

Nummer

11

Sidor

2537-2546

Publikationsforum

50179

Publikationsforumsnivå

2

Öppen tillgång

Öppen tillgänglighet i förläggarens tjänst

Ja

Öppen tillgång till publikationskanalen

Delvis öppen publikationskanal

Parallellsparad

Ja

Övriga uppgifter

Vetenskapsområden

Kemi; Farmaci; Biokemi, cell- och molekylärbiologi; Biomedicinska vetenskaper; Cancersjukdomar

Identifierade tema

[object Object]

Publiceringsland

Förenta staterna (USA)

Förlagets internationalitet

Internationell

Språk

engelska

Internationell sampublikation

Ja

Sampublikation med ett företag

Nej

DOI

10.1021/acschembio.1c00611

Publikationen ingår i undervisnings- och kulturministeriets datainsamling

Ja